Jennifer Good | President and Chief Executive Officer |
Chris Seiter | Chief Financial Officer |
Gary Nachman | BMO Capital Markets |
Ami Fadia | Leerink |
Serge Belanger | Needham & Company |
Annabel Samimy | Stifel |
Good afternoon, and welcome to the Trevi Therapeutics Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this call may be recorded. Various remarks that management makes during this call about the company’s future expectations, plans and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995.